Barclays’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $669K | Sell |
142,412
-194,113
| -58% | -$985K | ﹤0.01% | 3002 |
|
|
2025
Q4 | $1.43M | Buy |
336,525
+335,035
| +22,486% | +$1.27M | ﹤0.01% | 3180 |
|
|
2025
Q3 | $4.75K | Buy |
1,490
+1,488
| +74,400% | +$3.35K | ﹤0.01% | 5086 |
|
|
2025
Q2 | $5 | Hold |
2
| – | – | ﹤0.01% | 5168 |
|
|
2025
Q1 | $1 | Buy |
+2
| New | +$2 | ﹤0.01% | 5226 |
|
|
2022
Q2 | – | Sell |
-10,528
| Closed | -$28K | – | 5064 |
|
|
2022
Q1 | $28K | Sell |
10,528
-68,202
| -87% | -$262K | ﹤0.01% | 4326 |
|
|
2021
Q4 | $341K | Sell |
78,730
-32,123
| -29% | -$188K | ﹤0.01% | 3364 |
|
|
2021
Q3 | $564K | Sell |
110,853
-15,928
| -13% | -$85.3K | ﹤0.01% | 3126 |
|
|
2021
Q2 | $802K | Sell |
126,781
-10,523
| -8% | -$81.9K | ﹤0.01% | 2809 |
|
|
2021
Q1 | $1.06M | Buy |
137,304
+47,290
| +53% | +$374K | ﹤0.01% | 2739 |
|
|
2020
Q4 | $589K | Buy |
90,014
+60,474
| +205% | +$432K | ﹤0.01% | 3140 |
|
|
2020
Q3 | $197K | Sell |
29,540
-5,122
| -15% | -$38K | ﹤0.01% | 3857 |
|
|
2020
Q2 | $289K | Buy |
34,662
+11,295
| +48% | +$105K | ﹤0.01% | 3786 |
|
|
2020
Q1 | $179K | Sell |
23,367
-30,926
| -57% | -$216K | ﹤0.01% | 4393 |
|
|
2019
Q4 | $452K | Buy |
54,293
+27,774
| +105% | +$187K | ﹤0.01% | 4386 |
|
|
2019
Q3 | $196K | Sell |
26,519
-8,809
| -25% | -$86.9K | ﹤0.01% | 4979 |
|
|
2019
Q2 | $397K | Sell |
35,328
-5,054
| -13% | -$53K | ﹤0.01% | 4539 |
|
|
2019
Q1 | $434K | Buy |
40,382
+38,682
| +2,275% | +$572K | ﹤0.01% | 4248 |
|
|
2018
Q4 | $26K | Sell |
1,700
-15,622
| -90% | -$232K | ﹤0.01% | 5778 |
|
|
2018
Q3 | $321K | Sell |
17,322
-667
| -4% | -$15.2K | ﹤0.01% | 4630 |
|
|
2018
Q2 | $411K | Buy |
17,989
+1,957
| +12% | +$50K | ﹤0.01% | 4135 |
|
|
2018
Q1 | $457K | Sell |
16,032
-4,838
| -23% | -$138K | ﹤0.01% | 4064 |
|
|
2017
Q4 | $441K | Sell |
20,870
-6,516
| -24% | -$135K | ﹤0.01% | 3982 |
|
|
2017
Q3 | $497K | Buy |
27,386
+18,235
| +199% | +$285K | ﹤0.01% | 3629 |
|
|
2017
Q2 | $142K | Sell |
9,151
-3,669
| -29% | -$55.3K | ﹤0.01% | 4646 |
|
|
2017
Q1 | $221K | Buy |
12,820
+12,591
| +5,498% | +$166K | ﹤0.01% | 4209 |
|
|
2016
Q4 | $3K | Sell |
229
-120
| -34% | -$1.45K | ﹤0.01% | 6245 |
|
|
2016
Q3 | $5K | Buy |
+349
| New | +$4.22K | ﹤0.01% | 5997 |
|
|
2016
Q1 | – | Sell |
-167
| Closed | -$3K | – | 6175 |
|
|
2015
Q4 | $3K | Buy |
+167
| New | +$2.64K | ﹤0.01% | 5669 |
|
Other funds holding CTMX
KCM
PA
VA
VCM
